Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Parkinson's Disease

Free Subscription 29.03.2021 1 BMC Neurol 1 Brain Res 1 Exp Neurol 3 J Neural Transm (Vienna) 1 J Neurol Neurosurg Psychiatry 1 Lancet Neurol 8 Mov Disord 6 Neurology 1 PLoS One 1 Rev Neurol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. XING T, Ma J, Ou T
   Evaluation of neurogenic bladder outlet obstruction mimicking sphincter bradykinesia in male patients with Parkinson's disease.
   BMC Neurol. 2021;21:125.
   PubMed         Abstract available
   
   

   
   Brain Res

2. SUBRAHMANIAN N, LaVoie MJ
   Is there a special relationship between complex I activity and nigral neuronal loss in Parkinson's disease? A critical reappraisal.
   Brain Res. 2021 Mar 18:147434. doi: 10.1016/j.brainres.2021.147434.
   PubMed         Abstract available
   
   

   
   Exp Neurol

3. BECKSTEAD MJ, Howell RD
   Progressive parkinsonism due to mitochondrial impairment: Lessons from the MitoPark mouse model.
   Exp Neurol. 2021 Mar 19:113707. doi: 10.1016/j.expneurol.2021.113707.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

4. CUELLO AC
   Ted Sourkes, Moussa Youdim and I.
   J Neural Transm (Vienna). 2020;127:119-123.
   PubMed        
   
   
5. BOUGEA A, Stefanis L, Emmanouilidou E, Vekrelis K, et al
   High discriminatory ability of peripheral and CFSF biomarkers in Lewy body diseases.
   J Neural Transm (Vienna). 2020;127:311-322.
   PubMed         Abstract available
   
   
6. VARESLIJA D, Tipton KF, Davey GP, McDonald AG, et al
   6-Hydroxydopamine: a far from simple neurotoxin.
   J Neural Transm (Vienna). 2020;127:213-230.
   PubMed         Abstract available
   
   

   
   J Neurol Neurosurg Psychiatry

7. PHILLIPS O, D'Abreu A, Friedman JH, Akbar U, et al
   Recognising hemihypomimia as a mimic of 'facial weakness'.
   J Neurol Neurosurg Psychiatry. 2020;91:1357-1358.
   PubMed        
   
   

   
   Lancet Neurol

8. KIRBY T
   Maria Rodriguez-Oroz: leading the research to prevent cognitive decline in Parkinson's disease.
   Lancet Neurol. 2021;20:259.
   PubMed        
   
   

   
   Mov Disord

9. FEARON C, Lang AE, J Espay A
   Reply to: "The Logic and Pitfalls of Parkinson's as Brain- Versus Body-First Subtypes".
   Mov Disord. 2021;36:786-787.
   PubMed        
   
   
10. BORGHAMMER P, Horsager J
    The Logic and Pitfalls of Parkinson's as Brain- Versus Body-First Subtypes.
    Mov Disord. 2021;36:785-786.
    PubMed        
    
    
11. FEARON C, Lang AE, Espay AJ
    The Logic and Pitfalls of Parkinson's Disease as "Brain-First" Versus "Body-First" Subtypes.
    Mov Disord. 2021;36:594-598.
    PubMed        
    
    
12. GAURAV R, Yahia-Cherif L, Pyatigorskaya N, Mangone G, et al
    Longitudinal Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Progression Marker.
    Mov Disord. 2021 Mar 10. doi: 10.1002/mds.28531.
    PubMed         Abstract available
    
    
13. YAO CW, Saha-Chaudhuri P, Zolfaghari S, Pelletier A, et al
    Phenoconversion from Possible REM Sleep Behavior to Parkinsonism in the Population-Based CLSA.
    Mov Disord. 2021 Mar 22. doi: 10.1002/mds.28571.
    PubMed        
    
    
14. ABRAHAM DS, Pham Nguyen TP, Willis AW
    Claims-Based Frailty and Outcomes: Applying an Aging Measure to Older Adults with Parkinson's Disease.
    Mov Disord. 2021 Mar 23. doi: 10.1002/mds.28561.
    PubMed         Abstract available
    
    
15. GROVER S, Kumar-Sreelatha AA, Bobbili DR, May P, et al
    Replication of a Novel Parkinson's Locus in a European Ancestry Population.
    Mov Disord. 2021 Mar 24. doi: 10.1002/mds.28546.
    PubMed         Abstract available
    
    
16. KANG X, Ploner A, Roelstraete B, Khalili H, et al
    Association between Microscopic Colitis and Parkinson's Disease in a Swedish Population.
    Mov Disord. 2021 Mar 25. doi: 10.1002/mds.28594.
    PubMed         Abstract available
    
    

    
    Neurology

17. SIEGLER JE, Galetta S
    Editors' Note: Deep Brain Stimulation in Early-Stage Parkinson Disease: Five-Year Outcomes.
    Neurology. 2021;96:590.
    PubMed        
    
    
18. FASANO A, Bhowmick SS
    Reader Response: Deep Brain Stimulation in Early-Stage Parkinson Disease: Five-Year Outcomes.
    Neurology. 2021;96:590-591.
    PubMed        
    
    
19. CHARLES D, Hacker ML, Davis TL, Konrad PE, et al
    Author Response: Deep Brain Stimulation in Early-Stage Parkinson Disease: Five-Year Outcomes.
    Neurology. 2021;96:591.
    PubMed        
    
    
20. SIDIROPOULOS C
    Reader Response: Deep Brain Stimulation in Early-Stage Parkinson Disease: Five-Year Outcomes.
    Neurology. 2021;96:591-592.
    PubMed        
    
    
21. HACKER ML, Konrad PE, Davis TL, Charles D, et al
    Author Response: Deep Brain Stimulation in Early-Stage Parkinson Disease: Five-Year Outcomes.
    Neurology. 2021;96:592.
    PubMed        
    
    
22. TANG X, Zhang Y, Liu D, Hu Y, et al
    Association of Gyrification Pattern, White Matter Changes, and Phenotypic Profile in Patients With Parkinson Disease.
    Neurology. 2021 Mar 25. pii: WNL.0000000000011894.
    PubMed         Abstract available
    
    

    
    PLoS One

23. SEBATE B, Cuttler K, Cloete R, Britz M, et al
    Prioritization of candidate genes for a South African family with Parkinson's disease using in-silico tools.
    PLoS One. 2021;16:e0249324.
    PubMed         Abstract available
    
    

    
    Rev Neurol

24. MUNOZ-SALGADO M, Del Rio D
    [Object and action naming in a sentence context in people with Parkinson's disease free of dementia].
    Rev Neurol. 2021;72:223-230.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: